Clinical Trials
3 trialsActive not recruiting × FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma × Gynecologic × Clear all
NCT05538897 2026-05-13
Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
National Cancer Institute (NCI)
Phase 1/2 Active not recruiting
NCT04604613 2026-03-09
Prediction of Recurrence Among Low Risk Endometrial Cancer Patients
M.D. Anderson Cancer Center
Active not recruiting
NCT06213571 2026-01-09
Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas
Mayo Clinic
Phase NA Active not recruiting